Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Eli Lilly to expand long-standing Purdue University partnership with $250m investment

The alliance will aim to bring medicines to patients faster using advanced technologies

- PMLiVE

AbbVie’s Emrelis granted FDA accelerated approval to treat advanced lung cancer

An estimated 226,650 people will be diagnosed with lung cancer in the US this year

- PMLiVE

Why Health Comms Teams Can’t Afford to Skip the Mid-Year Review

New McKinsey and Gartner data show that organisations who regularly reset strategy can outperform peers by up to 60%. In fast-moving health communications, the mid-year review is a crucial but...

Fox&Cat

- PMLiVE

GSK to acquire Boston’s liver disease candidate efimosfermin in deal worth up to $2bn

Steatotic liver disease affects approximately 5% of the global population

- PMLiVE

Cytokinetics shares positive phase 3 results for aficamten in heart disease

Up to one in 500 people in the UK and US are living with hypertrophic cardiomyopathy

- PMLiVE

Madrigal’s liver disease drug Rezdiffra shows promise in compensated MASH cirrhosis

The drug has already been approved in the US to treat patients with non-cirrhotic MASH

- PMLiVE

Roche’s Perjeta-based breast cancer regimen shows sustained survival benefits

Approximately 56,800 new breast cancer cases are diagnosed in the UK every year

- PMLiVE

Johnson & Johnson’s bladder cancer therapy Balversa accepted by SMC

Almost 1,700 people are diagnosed with bladder cancer in Scotland annually

- PMLiVE

Eli Lilly’s Zepbound shows superiority in head-to-head weight loss study

Patients treated with Lilly’s drug achieved an average weight reduction of 20.2%

- PMLiVE

Intersection of Leadership and Advocacy: Driving Change Together for Women

We can’t talk about challenges to women’s reproductive health without acknowledging that we’re living in unprecedented times, say two mission-driven women’s healthcare leaders. Stephanie Sober, MD, MSHP, Global Director, Medical...

Medscape Education

Pharma Chatbots

Smarter, Compliant Engagement: Why Pharma is Warming Up to Chat-Based Solutions

Pharma marketers are embracing chat-based tools to engage HCPs and patients faster, simplify PI sharing, and gain real-time insights — all while staying ABPI and GDPR compliant. When aligned with...

Genetic Digital

- PMLiVE

Takeda’s Adzynma approved by MHRA for rare blood clotting disorder cTTP

The enzyme replacement therapy is now the first treatment approved in the UK for this patient population

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links